Information regarding Malignant Pleural Mesothelioma recently got updated
at the 12 th World Conference on Lung Cancer.
Malignant Pleural Mesothelioma is a tumor that arises from the pleural
and peritoneal cavities and is linked to asbestos exposure. Malignant
Pleural Mesothelioma Statistics According to reports, there are over
2,000 cases of Malignant Pleural Mesothelioma diagnosed annually in the
U.S. About 80 percent of cases reportedly originate in the pleura.
Patients who suffer from this illness typically experience chest pain and
symptoms of dyspnea. For patients in the early stages of the disease,
systemic treatment with chemotherapy has been administered and has been
temporarily successful. Systemic Therapy For patients suffering from
Malignant Pleural Mesothelioma, a combination treatment that mixes
cisplatin and pemetrexed has become the standard therapy used. A
study was recently conducted analyzing patients with Malignant Pleural
Mesothelioma who were receiving this type of treatment. In the study,
some patients were given cisplatin alone while others were given
cisplatin with pemetrexed. Researchers found that there was the most
progression and benefits in receiving the combination of both and those
treated this way had a longer mesothelioma survival rate. (Source: Daily
Cancer News) Are you living with mesothelioma cancer? If so, please
contact mesothelioma center to speak with someone about the resources
available to you.
Related Articles -
malignant pleural mesothelioma, lung cancer, asbestos exposure,
statistics, mpm, treatment, systemic therapy,
Email this Article to a Friend!
Receive Articles like this one direct to your email box!Subscribe for